Intelligent Investment
Mexico City Market
Global Life Sciences Atlas
April 11, 2025 5 Minute Read
Overview
- Mexican exports of pharmaceutical products have increased steadily since the COVD-19 pandemic, doubling in volume compared with the five-year average between 2016-2020. The majority of these sales originate from Mexico City.
- Approximately 400 laboratories manufacture pharmaceuticals in Mexico, mostly in the Mexico City metropolitan area.
- Mexico City’s life sciences corporate sector is mostly concentrated in Polanco, Insurgentes, Periferico Sur and Periferico Norte.
- Manufacturing space is the only recently completed life sciences construction in Mexico City. Other life sciences manufacturing projects are underway in Guadalajara, Hidalgo and Tijuana.
- The Mexican pharmaceutical industry stands out because of the presence of 20 out of the 25 largest companies worldwide.
Submarkets

Figure 1: Mexican Exports in Pharmaceutical Products
Millions USD
Industry Presence
- Foreign direct investment in pharmaceutical products manufacturing in Mexico City has increased significantly in recent years.
Figure 2: FDI in Pharmaceutical and Medicine Manufacturing
Life Sciences Market Stats
Figure 3: Life Sciences Office Gross Absorption (SM)
Development Pipeline or Activity
Figure 4: Under Construction Projects to Be Delivered
Figure 5: Recently Delivered Projects
- Abbott Laboratories
- Abbvie
- Amgen
- AstraZeneca
- Bayer AG
- Bristol-Myers Squibb
- Eli Lilly
- GSK
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi
- Takeda